|
NUP214 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.67500005374433E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.03349999961367E-08 |
| Normal-vs-Stage2 |
3.036100E-04 |
| Normal-vs-Stage3 |
6.73669999784465E-08 |
| Normal-vs-Stage4 |
4.7176999973253E-08 |
| Stage1-vs-Stage2 |
9.732000E-01 |
| Stage1-vs-Stage3 |
1.847240E-01 |
| Stage1-vs-Stage4 |
1.269440E-01 |
| Stage2-vs-Stage3 |
4.050600E-01 |
| Stage2-vs-Stage4 |
2.733200E-01 |
| Stage3-vs-Stage4 |
6.776600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.3514999997486E-08 |
| Normal-vs-AfricanAmerican |
6.573000E-04 |
| Normal-vs-Asian |
9.83089999999631E-05 |
| Caucasian-vs-AfricanAmerican |
9.255400E-01 |
| Caucasian-vs-Asian |
2.912600E-01 |
| AfricanAmerican-vs-Asian |
5.336200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22719999999343E-05 |
| Normal-vs-Female |
6.35549946004232E-10 |
| Male-vs-Female |
3.131400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.34560000498408E-08 |
| Normal-vs-Age(41-60Yrs) |
3.12780000011337E-07 |
| Normal-vs-Age(61-80Yrs) |
1.2068000043719E-08 |
| Normal-vs-Age(81-100Yrs) |
1.096780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.599000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.816430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.613600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.608200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.482800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.809800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.695800E-02 |
| Classical-VS-Follicular |
1.223970E-02 |
| Classical-VS-Other |
1.850400E-01 |
| Classical-VS-Normal |
6.10479999996194E-07 |
| Tall-VS-Follicular |
6.163000E-01 |
| Tall-VS-Other |
8.400600E-01 |
| Tall-VS-Normal |
2.25309999990486E-07 |
| Follicular-VS-Other |
6.966200E-01 |
| Follicular-VS-Normal |
8.50600000434909E-08 |
| Other-VS-Normal |
2.115700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.81300000012818E-07 |
| Normal-vs-N1 |
2.72800000367113E-08 |
| N0-vs-N1 |
1.637570E-01 |
|
|
